Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01902771
What this trial is testing

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Who this might be right for
GliomaBrain CancerBrain Tumor+2 more
Edward Ziga 1
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Not applicableLooking for participantsNCT05464992
What this trial is testing

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Who this might be right for
GliomaBrain Metastases
Centre Paul Strauss 800
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT00021307
What this trial is testing

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257
Early research (Phase 1)Study completedNCT01688401
What this trial is testing

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

Who this might be right for
Diffuse Intrinsic Pontine Glioma (DIPG)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00003134
What this trial is testing

Irinotecan in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 64
Not applicableStudy completedNCT06368310
What this trial is testing

FIH Clinical Investigation of Graphene Electrodes for Brain Mapping

Who this might be right for
Brain TumorGlioma
University of Manchester 10
Testing effectiveness (Phase 2)Study completedNCT00540722
What this trial is testing

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00006386
What this trial is testing

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 80
Early research (Phase 1)Ended earlyNCT04963413
What this trial is testing

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Who this might be right for
Glioblastoma
University of Florida 6
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Testing effectiveness (Phase 2)Ended earlyNCT03173950
What this trial is testing

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Who this might be right for
MedulloblastomaEpendymomaPineal Region Tumors+2 more
National Cancer Institute (NCI) 136
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Early research (Phase 1)Study completedNCT00005813
What this trial is testing

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Study completedNCT00961090
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Who this might be right for
Glioblastoma
Matthew R Quigley 72
Testing effectiveness (Phase 2)Ended earlyNCT01517776
What this trial is testing

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

Who this might be right for
Gliomas
Martin-Luther-Universität Halle-Wittenberg 28
Early research (Phase 1)Looking for participantsNCT07390539
What this trial is testing

B7-H3.CD28Z.CART in CNS Neoplasms

Who this might be right for
Central Nervous System NeoplasmsBrain TumorBrain Tumor, Recurrent+11 more
Robbie Majzner 70
Next Page